These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37713940)

  • 1. Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy.
    Jaikuna T; Osorio EV; Azria D; Chang-Claude J; De Santis MC; Gutiérrez-Enríquez S; van Herk M; Hoskin P; Lambrecht M; Lingard Z; Seibold P; Seoane A; Sperk E; Symonds RP; Talbot CJ; Rancati T; Rattay T; Reyes V; Rosenstein BS; de Ruysscher D; Vega A; Veldeman L; Webb A; West CML; Aznar MC
    Breast; 2023 Dec; 72():103578. PubMed ID: 37713940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials.
    Mukesh MB; Harris E; Collette S; Coles CE; Bartelink H; Wilkinson J; Evans PM; Graham P; Haviland J; Poortmans P; Yarnold J; Jena R
    Radiother Oncol; 2013 Aug; 108(2):293-8. PubMed ID: 23953408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ipsilateral lung normal tissue complication probability parameters for different dose calculation algorithms in radiotherapy of breast cancer.
    Kavousi N; Nedaie HA; Gholami S; Esfahani M; Shafiekhani S; Hassani M
    J Cancer Res Ther; 2020; 16(6):1323-1330. PubMed ID: 33342791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients.
    Pastore F; Conson M; D'Avino V; Palma G; Liuzzi R; Solla R; Farella A; Salvatore M; Cella L; Pacelli R
    Acta Oncol; 2016; 55(4):466-73. PubMed ID: 26623532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy.
    Dell'Oro M; Wilson P; Short M; Hua CH; Merchant TE; Bezak E
    Med Phys; 2022 Jan; 49(1):742-755. PubMed ID: 34796509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
    Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability.
    Fiorino C; Vavassori V; Sanguineti G; Bianchi C; Cattaneo GM; Piazzolla A; Cozzarini C
    Radiother Oncol; 2002 Jun; 63(3):249-55. PubMed ID: 12142088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
    Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
    Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel methodology to assess the effect of contouring variation on treatment outcome.
    Jenkins A; Mullen TS; Johnson-Hart C; Green A; McWilliam A; Aznar M; van Herk M; Vasquez Osorio E
    Med Phys; 2021 Jun; 48(6):3234-3242. PubMed ID: 33772803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study.
    Leonardi MC; Pepa M; Luraschi R; Vigorito S; Dicuonzo S; Isaksson LJ; La Porta MR; Marino L; Ippolito E; Huscher A; Argenone A; De Rose F; Cucciarelli F; De Santis MC; Rossi F; Prisco A; Guarnaccia R; Tabarelli de Fatis P; Palumbo I; Colangione SP; Mormile M; Ravo V; Fozza A; Aristei C; Orecchia R; Cattani F; Jereczek-Fossa BA;
    Radiother Oncol; 2022 Mar; 168():113-120. PubMed ID: 35033602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric predictors and Lyman normal tissue complication probability model of hematological toxicity in cervical cancer patients with treated with pelvic irradiation.
    Wang D; Yin Y; Zhou Q; Li Z; Ma X; Yin Y; Li B; Bai T; Li D; Zhu J
    Med Phys; 2022 Jan; 49(1):756-767. PubMed ID: 34800297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy.
    Mavroidis P; Pearlstein KA; Dooley J; Sun J; Saripalli S; Das SK; Wang AZ; Chen RC
    Radiat Oncol; 2018 Feb; 13(1):17. PubMed ID: 29394931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of different dose calculation algorithms on the estimate of NTCP for lung complications.
    Hedin E; Bäck A
    J Appl Clin Med Phys; 2013 Sep; 14(5):127-39. PubMed ID: 24036865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating how contouring differences affect normal tissue complication probability modelling.
    Fernandes MG; Bussink J; Wijsman R; Stam B; Monshouwer R
    Phys Imaging Radiat Oncol; 2024 Jan; 29():100533. PubMed ID: 38292649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
    Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
    Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal tissue complication probability (NTCP) models of acute urinary toxicity (AUT) following carbon ion radiotherapy (CIRT) for prostate cancer.
    Li Y; Li P; Hsi W; Hong Z; Fu S; Zhang Q
    Radiother Oncol; 2021 Mar; 156():69-79. PubMed ID: 33309999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric factors and Lyman normal-tissue complication modelling analysis for predicting radiation-induced lung injury in postoperative breast cancer radiotherapy: a prospective study.
    Zhou ZR; Han Q; Liang SX; He XD; Cao NY; Zi YJ
    Oncotarget; 2017 May; 8(20):33855-33863. PubMed ID: 27806340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy.
    Alexander MA; Brooks WA; Blake SW
    Phys Med Biol; 2007 Apr; 52(7):1831-43. PubMed ID: 17374914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.